ESMO 2024 Insights: TACE ± Lenvatinib + Pembro for Int-Stage HCC - Ph3 LEAP-012 Study | VuMedi

Find latest Hepatocellular Cancer videos · 200+ videos

Video Player is loading.

Current Time 0:00

Duration 0:00

Loaded: 0%

Stream Type LIVE

10 seconds

Playback speed

This video is featured in the 2024 ESMO Annual Meeting Insights Hub

2024 ESMO Annual Meeting Insights Hub

ESMO 2024 Insights: TACE ± Lenvatinib + Pembro for Int-Stage HCC - Ph3 LEAP-012 Study

By 2024 ESMO Annual Meeting Insights Hub FEATURING Josep Llovet

By 2024 ESMO Annual Meeting Insights Hub FEATURING Josep Llovet

224 views

September 23, 2024

Comments 0

Login to view comments. Click here to Login